ARNA Market Cap History
Below is a table of the ARNA market cap history going back to 6/19/2017:

Date ARNA Market Cap
6/19/2017445.36M
8/4/2017912.26M
11/3/20171.12B
3/9/20181.67B
5/4/20182.12B
8/2/20181.92B
11/2/20181.89B
2/22/20192.49B
5/3/20192.36B
8/2/20193.05B
5/18/2006117.79M
11/1/20192.50B
2/21/20202.65B
5/1/20202.39B
7/31/20203.54B

Also see: ARNA Shares Outstanding History
and ARNA YTD Return
ARNA Historical Market Cap:
+94.41% CAGR
ARNA Historical Market Cap: +94.41% CAGR

Mouse over chart for data details
6/19/2017 ...7/31/2020
Arena Pharmaceuticals is a biopharmaceutical company focused on delivering medicines with pharmacology and pharmacokinetics to patients globally. Co.'s clinical programs include: etrasimod (APD334), which is being evaluated in ulcerative colitis, a program for Crohn's disease, as well as a program for atopic dermatitis; olorinab (APD371), which is is being evaluated for a range of visceral pain conditions associated with gastrointestinal diseases and for treatment of abdominal pain associated with irritable bowel syndrome; and APD418, which is being evaluated in a trial for acute heart failure. We show 15 historical shares outstanding datapoints in our ARNA shares outstanding history coverage, used to compute ARNA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ARNA market cap history over the course of time is important for investors interested in comparing ARNA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ARNA versus a peer is one thing; comparing ARNA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ARNA can fluctuate over the course of history. With this page we aim to empower investors researching ARNA by allowing them to research the ARNA market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ARNA:
ARNA SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Arena Pharmaceuticals (ARNA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ARQL Market Cap History
ARRY Market Cap History
ARWR Market Cap History
ASMB Market Cap History
ASNS Market Cap History
ATEC Market Cap History
ATHX Market Cap History
ATNX Market Cap History
ATOS Market Cap History
ATRA Market Cap History
More Healthcare companies »

 

ARNA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.